Sesame Seed Extract for Health & Longevity - Quick Reference Sheet

Sesame Seed Extract for Health & Longevity

Created on 10/06/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Sesame seed extract, a dietary supplement of concentrated sesame plant compounds, is used for blood pressure, cholesterol and blood sugar. Small, short trials suggest slightly lower blood pressure and harmful cholesterol, better blood sugar control in type 2 diabetes and less rheumatoid arthritis joint pain; some found no effect; those with already-healthy levels may gain little. Longevity appeal rests on worm and fly studies. Sesame allergy is the main risk. (Full Review)

Protocol

Moderate dose for blood pressure
60 mg/day sesamin
For 4 weeks; 50 mg/day sesame lignans was the dose in the 28-day safety study
Higher dose for metabolic or inflammatory conditions
200 mg/day sesamin
For 6–8 weeks in type 2 diabetes and rheumatoid arthritis trials
Time of day
With a fat-containing meal
Levels peak about 5 hours later; morning and evening dosing have both been used
Time to effect
Blood sugar and HbA1c
Within 8 weeks
200 mg/day sesamin in type 2 diabetes
Cholesterol
6 weeks or more
Changes were larger in trials lasting 6 weeks or more
Blood pressure
Within 4 weeks
60 mg/day sesamin in mild hypertension

Benefits

Contraindications
  • Diagnosed sesame allergy or any prior reaction to sesame
  • Pregnancy or breastfeeding
  • Tamoxifen use or estrogen-responsive breast cancer (theoretical)
  • Warfarin with unstable INR (theoretical)
  • Sesame oral immunotherapy: avoid unsupervised use (theoretical)
Key Interactions
  • CYP2C9 substrates (warfarin, phenytoin, glipizide, celecoxib): Caution (theoretical)
  • CYP2C19 substrates (omeprazole, citalopram, clopidogrel): Monitor (theoretical)
  • Antihypertensives (amlodipine, lisinopril, losartan, hydrochlorothiazide): Monitor (theoretical)
  • Glucose-lowering drugs (metformin, glipizide, glimepiride, insulin): Monitor (theoretical)
  • Ivabradine (a heart-rate-lowering heart drug): Monitor (theoretical)
  • Over-the-counter NSAIDs (non-steroidal anti-inflammatory drugs: ibuprofen, naproxen, diclofenac): Monitor (theoretical)
  • P-glycoprotein (a drug-exporting cell pump) substrates (fexofenadine, cyclosporine, loperamide): Monitor (theoretical)
  • Vitamin E supplements: Monitor
  • Fish oil (EPA and DHA, the marine omega-3 fats): Monitor (theoretical)
  • Supplements with additive effects (garlic, hibiscus, berberine, cinnamon): Monitor (theoretical)
  • Dietary sesame: Monitor

Risk & Side Effects

  • High:
  • Medium:
  • Low: Allergic reactions in people with sesame allergy
  • Speculative: Shifts in sex hormones, slower breakdown of some drugs such as warfarin, raised liver fat-burning enzymes at high doses, reduced tamoxifen effect, excess lowering of blood pressure or blood sugar

Monitoring

Marker Target Why
Home blood pressure No established target; track change from own pre-supplement average Expected to change; safety check with antihypertensives
LDL cholesterol (with total cholesterol and triglycerides) No established target; track change from own baseline Expected to change
HbA1c (with fasting glucose) 4.0–5.6% (standard reference range) Expected to change in diabetes; safety check with glucose-lowering drugs
ALT (with AST) About 7–55 U/L (varies by laboratory) Safety check: a sustained rise stops use
INR (warfarin users only) No established target for supplement use; track against the prescriber's therapeutic range Safety check: a rise prompts stopping and prescriber review

Cadence: Baseline before starting; blood pressure weekly for the first month, then monthly; lipids, HbA1c and ALT at 8–12 weeks, then every 6–12 months while continuing; INR 1–2 weeks after starting or stopping (warfarin users)

Qualitative Assessment

  • Joint pain and morning stiffness (rheumatoid arthritis users)
  • Daytime energy and fatigue
  • Dizziness or light-headedness on standing
  • Itching, hives, lip or throat swelling after doses (a reason to stop use)
  • Unusual bruising or bleeding (warfarin users)